The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[4-[(5,11-dimethyl-6-oxo-pyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-3-methoxy-phenyl]methanesulfonamide ID: ALA4636475
PubChem CID: 134457889
Max Phase: Preclinical
Molecular Formula: C21H22N6O4S
Molecular Weight: 454.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NS(C)(=O)=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C
Standard InChI: InChI=1S/C21H22N6O4S/c1-26-16-8-6-5-7-14(16)20(28)27(2)17-12-22-21(24-19(17)26)23-15-10-9-13(11-18(15)31-3)25-32(4,29)30/h5-12,25H,1-4H3,(H,22,23,24)
Standard InChI Key: ISCJKSNXTHTNBW-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
3.2664 -3.8713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8692 -4.4415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6121 -4.0965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6121 -3.2703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3546 -4.4613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9351 -3.8767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5343 -5.2644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3347 -5.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6224 -6.1694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1029 -6.7975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3168 -7.5961 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1152 -7.8099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3304 -8.6092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1301 -8.8204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7089 -8.2383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5075 -8.4521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0879 -7.8674 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.5084 -7.2818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3024 -7.0668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8865 -8.0813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4951 -7.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7002 -7.2254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4864 -6.4269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0711 -5.8464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2984 -6.6679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0091 -5.8955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1833 -5.8955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7722 -6.6095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6772 -5.2444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8855 -5.4786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2862 -4.9116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4784 -4.1097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 2 0
3 5 1 0
5 6 1 0
5 7 1 0
7 8 1 0
9 8 2 0
10 9 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
16 15 1 0
16 17 1 0
17 18 2 0
17 19 2 0
17 20 1 0
15 21 2 0
21 22 1 0
22 12 2 0
22 23 1 0
23 24 1 0
25 10 2 0
26 25 1 0
7 26 2 0
27 26 1 0
27 28 1 0
29 27 1 0
2 29 2 0
29 30 1 0
31 30 2 0
32 31 1 0
1 32 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 454.51Molecular Weight (Monoisotopic): 454.1423AlogP: 2.96#Rotatable Bonds: 5Polar Surface Area: 116.76Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.57CX Basic pKa: 3.32CX LogP: 1.62CX LogD: 1.62Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.60Np Likeness Score: -1.32
References 1. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS.. (2020) Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H -benzo[e ]pyrimido[5,4-b ][1,4]diazepin-6-one Scaffold., 63 (14): [PMID:32530623 ] [10.1021/acs.jmedchem.0c00596 ]